Stopped flow fluorescence energy transfer measurement of the rate constants describing the reversible formation and the irreversible rearrangement of the elastase-α1-proteinase inhibitor complex

被引:25
作者
Mellet, P
Boudier, C
Mely, Y
Bieth, JG
机构
[1] Univ Louis Pasteur Strasbourg 1, Enzymol Lab, INSERM, U392, F-67000 Strasbourg, France
[2] Univ Louis Pasteur Strasbourg 1, CNRS, URA 491, Biophys Lab, F-67000 Strasbourg, France
关键词
D O I
10.1074/jbc.273.15.9119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serpins are thought to inhibit proteinases by first forming a Michaelis-type complex that later converts into a stable inhibitory species, However, there is only circumstantial evidence for such a two-step reaction pathway, Here we directly observe the sequential appearance of two complexes by measuring the time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-alpha(1)-protease inhibitor, A moderately tight initial Michaelis-type complex EI1 (K-i = 0.38-0.52 mu M) forms and dissociates rapidly (k(1) = 1.5 x 10(6) M-1 s(-1), k(-1) = 0.58 s(-1)). EI1 then slowly converts into EI2 (k(2) = 0.13 s(-1)), the fluorescence intensity of which is stable for at least 50 s, The two species differ by their donor-acceptor energy transfer efficiency (0.41 and 0.26, respectively), EI2 might be the final product of the elastase + inhibitor association because its transfer efficiency is the same as that of a complex incubated for 30 min, The time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-eglin c, a canonical inhibitor, again allows the fast formation of a complex to be observed, However, this complex does not undergo any fluorescently detectable transformation.
引用
收藏
页码:9119 / 9123
页数:5
相关论文
共 39 条
[1]   Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases [J].
Aertgeerts, K ;
DeRanter, CJ ;
Booth, NA ;
Declerck, PJ .
JOURNAL OF STRUCTURAL BIOLOGY, 1997, 118 (03) :236-242
[2]   BETA-SHEET REARRANGEMENTS - SERPINS AND BEYOND [J].
BANZON, JA ;
KELLY, JW .
PROTEIN ENGINEERING, 1992, 5 (02) :113-115
[3]   CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS [J].
BAUMANN, U ;
HUBER, R ;
BODE, W ;
GROSSE, D ;
LESJAK, M ;
LAURELL, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) :595-606
[4]  
BEATTY K, 1980, J BIOL CHEM, V255, P3931
[5]   THE EFFECT OF ALPHA-2-MACROGLOBULIN ON THE INTERACTION OF ALPHA-1-PROTEINASE INHIBITOR WITH PORCINE TRYPSIN [J].
BEATTY, K ;
TRAVIS, J ;
BIETH, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 704 (02) :221-226
[6]  
BIETH JG, 1995, METHOD ENZYMOL, V248, P59
[7]   INVIVO SIGNIFICANCE OF KINETIC CONSTANTS OF PROTEIN PROTEINASE-INHIBITORS [J].
BIETH, JG .
BIOCHEMICAL MEDICINE, 1984, 32 (03) :387-397
[8]   THE HIGH-RESOLUTION X-RAY CRYSTAL-STRUCTURE OF THE COMPLEX FORMED BETWEEN SUBTILISIN CARLSBERG AND EGLIN-C, AN ELASTASE INHIBITOR FROM THE LEECH HIRUDO-MEDICINALIS - STRUCTURAL-ANALYSIS, SUBTILISIN STRUCTURE AND INTERFACE GEOMETRY .2. [J].
BODE, W ;
PAPAMOKOS, E ;
MUSIL, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 166 (03) :673-692
[9]   NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES [J].
BODE, W ;
HUBER, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :433-451
[10]  
BOUDIER C, 1992, J BIOL CHEM, V267, P4370